References
- Higgins JR, Brennecke SP Preeclampsia – still a disease of theories? Curr Opin Obstet Gynecol 1998; 10: 129–33.
- Mantzoros CS, Georgiadas EI, Young R, Evagelopoulou C, Khoury S, Katsilambros N et al. Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women. Am J Hypertens 1995; 8: 606–14.
- Bachnann J, Feldmer M, Ganten U, Stock G, Ganten G. Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991; 40: 511–15.
- Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG. Androgens in preeclampsia. Am J Obstet Gynecol 1999; 180: 60–3.
- Laivuori H, Kauja R, Rutanen EM, Viinikka L, Ylirkorko- la O. Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab 1998; 83: 344–7.
- American College of Obstetricians and Gynecologists . Hypertension in pregnancy. ACOG technical bulletin, Washington, 1996: no 219.
- Pierin WF, Garancis JG, Becker CG. Preeclampsia related to a functioning extrauterine placenta: report of a case and 25-year follow-up. Am J Kidney Dis 1993; 21: 310–13.
- Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 225: 1359–75.
- Walker JJ. Severe pre-eclampsia and eclampsia. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 57–71.
- Casey ML, MacDonald PC. Endocrine changes of pregnancy. In: Wilson JD, Farther DW, Kronenberg HM, Larsen PR (eds.): Williams Textbook of Endocrinology. Pennsylvania: W.B Saunders, 1999: 1259–72.
- Hahnel ME, Martin LD, Michael CA, Hahnel R. Metabolism of androstenodione by placental microsomes in pregnancy hypertension. Clin Chim Acta 1989; 181: 103–8.
- Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999; 10: 722–32.
- McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999; 99: 2317–22.
- Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, John CP. The cell adhesion molecule, VCAM-1 is selectively elevated in serum in preeclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol 1994; 101:485–7.
- Başbuğ M, Aygen E, Tayyar M, Tutus A, Kaya E, Öktem Ö. Correlation between maternal thyroid function tests and endothelin in preeclampsia-eclampsia. Obstet Gynecol 1999; 94: 551–5.
- Wakasugi M, Noguguchi T, Kazama YI, Kanemaru Y, Onaya T. The effects of sex hormones on the synthesis of prostocyclin (PGI2) by vascular tissues. Prostaglandins 1989; 37: 401–9.
- Milewich L, Whisenant MG. Metabolism of androstene- dione by human platelets: a source of potent androgens. J Clin Endocrinol Metab 1982; 54: 969–74.
- Reckelhof JF, Granger JP Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 1999; 26: 127–31.
- de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998; 76: 915.
- Fridström M, Nisell H, Sjöblom P, Hillensjö T. Are women with polycystic ovary syndrome at increased risk of pregnancy-induced hypertension and/or preeclampsia? Hypertens Pregn 1999; 18: 73–80.
- Radon PA, McMahan MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94: 194–7.
- Pigny P, Cortet-Rudelli C, Duhamel A, Deroubaix-Allard D, Racadot A, Dewailly D. Serum alpha-inhibin levels in polycystic ovarian syndrome: relationship to the serum an- drostenedione level. J Clin Endocrinol Metab 1997; 82: 1939–43.